Skip to ContentSkip to Navigation
Over onsFaculty of Science and EngineeringOnderzoekGRIPPharmacoTherapy, -Epidemiology & -Economics (PTEE)Publications

Publications 2013

Below our publications are listed using several headings. Scientific publications relate to original research, often published internationally, but also in the Dutch language. Professional publications are in Dutch and relate to reviews and expressions of opinions.

A few publications have no links. Reprints can be requested by our secretary

Scientific publication international
1

Alsaad N, van Altena R, Pranger AD, van Soolingen D, de Lange WC, van der Werf TS, Kosterink JG, Alffenaar JW. Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis. Eur Respir J 2013;42(2):504-12

2

Alsaad N, Wilffert B, van Altena R, de Lange WC, van der Werf TS, Kosterink JG, Alffenaar JW. Potential antimicrobial agents for the treatment of MDR-TB. Eur Respir J 2013;

3

Berm EJJ, Risselada AJ, Mulder H, Hak E, Wilffert B. Phenoconversion of Cytochrome P450 @D6: The Need for Identifying the Intermediate Metabolizer Genotype. J Clin Psychiatry 2013;74:1025-letter.

4

Bertholee D, Ter Horst PG, Hijmering ML, Spanjersberg AJ, Hospes W, Wilffert B. Blood concentrations of cefuroxime in cardiopulmonary bypass surgery. Int J Clin Pharm 2013;[Epub ahead of print]

5

Bijlsma MJ, Hak E, Bos J, De Jong-van den Berg LTW, Janssen F. Assessing the effect of a guideline change on drug use prevalence by including the birth cohort dimension: the case of benzodiazepines. Pharmacoepidemiol Drug Saf 2013;22(9):933-41

6

Bolhuis MS, Altena RV, Soolingen DV, Lange WC, Uges DR, Werf TS, Kosterink JG, Alffenaar JW. Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients. Eur Respir J 2013;

7

Bolhuis MS, van Altena R, van Hateren K, de Lange WC, Greijdanus B, Uges DR, Kosterink JG, van der Werf TS, Alffenaar JW. Clinical validation of the analysis of linezolid and clarithromycin in oral fluid of patients with multidrug-resistant tuberculosis. Antimicrob Agents Chemother 2013;57(8):3676-80

8

Bulsink A, Imholz AL, Brouwers JR, Jansman FG. Characteristics of potential drug-related problems among oncology patients. Int J Clin Pharm 2013;35(3):401-7

9

Bult W, Kroeze SG, Elschot M, Seevinck PR, Beekman FJ, de Jong HW, Uges DR, Kosterink JG, Luijten PR, Hennink WE, van Het Schip AD, Bosch JL, Nijsen JF, Jans JJ. Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer, PLoS One 2013;8:e52178.

10

Cohen D, Loonen AJ. Are immediate- and extended-release drugs interchangeable? Acta Psychiatr Scand 2013;127:78-80.

11

Connolly MP, Kuyvenhoven JP, Postma MJ, Nielsen SK. Cost and quality-adjusted life year differences in the treatment of active ulcerative colitis using once-daily 4 g or twice-daily 2 g mesalazine dosing. Journal of Crohn's and Colitis 2013, http://dx.doi.org/10.1016/j.crohns.2013.09.015

12 Crijns I, Mantel-Teeuwisse A, Bloemberg R, Pinas E, Straus S, de Jong-van den Berg L. Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study, Expert Opin Drug Saf 2013;12:29-38.
13

Darak S, Darak T, Kulkarni S, Kulkarni V, Parchure R, Hutter I, Janssen F. Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India. AIDS Patient Care STDS 2013;27(3):163-70

14

de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands, Vaccine 2013;31:1276-83.

15

de Jonge L, Bos HJ, van Langen IM, de Jong-van den Berg LT, Bakker MK. Antibiotics prescribed before, during and after pregnancy in the Netherlands: a drug utilization study. Pharmacoepidemiol Drug Saf 2013;

16

de Jonge L, Zetstra-van der Woude AP, Bos HJ, de Jong-van den Berg LT, Bakker MK. Identifying Associations between Maternal Medication Use and Birth Defects Using a Case-Population Approach: An Exploratory Study on Signal Detection. Drug Saf 2013;

17

Dijkstra A, Hak E, Janssen F. A systematic review of the application of spatial analysis in pharmacoepidemiologic research. Ann Epidemiol 2013;23(8):504-14

18

Dijkstra A, Janssen F, De Bakker M, Bos J, Lub R, Van Wissen LJ, Hak E. Using spatial analysis to predict health care use at the local level: a case study of type 2 diabetes medication use and its association with demographic change and socioeconomic status. PLoS One 2013;8(8):e72730

19

Dreischulte T, Johnson J, McAnaw J, Geurts M, de Gier H, Hudson S. Medication assessment tool to detect care issues from routine data: a pilot study in primary care. Int J Clin Pharm 2013;35:1063-74

20

Gefenaite G, Tacken M, Bos J, Stirbu-Wagner I, Korevaar JC, Stolk RP, Wolters B, Bijl M, Postma MJ, Wilschut J, Nichol KL, Hak E. Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination. PLoS One 2013;8(6):e66125

21

Gefenaite G, Tacken M, Kolthof J, Mulder B, Korevaar JC, Stirbu-Wagner I, Bos J, Stolk RP, Hak E. Predictors of influenza in the adult population during seasonal and A(H1N1)pdm09 pandemic influenza periods. Epidemiol Infect 2013;:1-5

22

Geurts MM, van der Flier M, de Vries-Bots AM, Brink-van der Wal TI, de Gier JJ. Medication reconciliation to solve discrepancies in discharge documents after discharge from the hospital. Int J Clin Pharm 2013;

23

Geurts MM, Zuydgeest IA, Walser S, Kijlstra NB, Petkova V, de Gier JJ. The evaluation of patient self-completion concordance forms used in community pharmacy: a comparison of two European countries. Int J Pharm Pract 2013;

24

Hak E, Shea KM, Jick SS. Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: A nested case-control study using the GPRD, Vaccine 2013.

25

Hak E, de Vries TW, Hoekstra PJ, Jick SS. Association of childhood attention-deficit/hyperactivity disorder with atopic diseases and skin infections? A matched case-control study using the General Practice Research Database. Ann Allergy Asthma Immunol 2013;111(2):102,106.e2

26

Hak E, Mulder B, Schuiling-Veninga CC, de Vries TW, Jick SS. Use of Acid-Suppressive Drugs in Pregnancy and the Risk of Childhood Asthma: Bidirectional Crossover Study using the General Practice Research Database. Drug Saf 2013;

27

Härmark L, Alberts S, van Puijenbroek E, Denig P, van Grootheest K. Representativeness of diabetes patients participating in a web-based adverse drug reaction monitoring system. Pharmacoepidemiol Drug Saf 2013;22(3):250-5

28

Härmark L, Lie-Kwie M, Berm L, de Gier H, van Grootheest K. Patients' motives for participating in active post-marketing surveillance. Pharmacoepidemiol Drug Saf 2013;22(1):70-6

29

Härmark L, van Puijenbroek E, van Grootheest K. Intensive monitoring of duloxetine: results of a web-based intensive monitoring study. Eur J Clin Pharmacol 2013;69(2):209-15

30

Härmark LV, Huls HJ, de Gier JJ, van Grootheest AC. Non-response in a pharmacy and patient-based intensive monitoring system: a quantitative study on non-response bias and reasons for non-response. Int J Pharm Pract 2013;

31

Hepkema H, Pouwels KB, van der Ende A, Westra TA, Postma MJ. Meningococcal serogroup a, C, w135 and y conjugated vaccine: a cost-effectiveness analysis in the Netherlands. PLoS One 2013;8(5):e65036

32

Hovens JE and Loonen AJ. Reaction on 'The aftermath of the reduction in inpatient care and treatment II: cross-sectional study relating to the health, the need for care, the quality of life, social functioning and the integration in society of chronic mental patients in Amsterdam'. Tijdschr Psychiatr 2013;55(5):387-8

33

Janssen F, van Wissen LJG, Kunst AE. Life expectancy is increasing - but by how much exactly? . Population Europe - Pop Digest 2013;22-07-2013

34

Janssen F, van Wissen LJ, Kunst AE. Including the smoking epidemic in internationally coherent mortality projections. Demography 2013;50(4):1341-62

35

Jiang Y, Gauthier A, Postma MJ, Ribassin-Majed L, Largeron N, Bresse X. A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus. Hum Vaccin Immunother 2013;9(11)

36

Kelso JK, Halder N, Postma MJ, Milne GJ. Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories. BMC Public Health 2013;13:211

37

Kibele E and Janssen F.   Distortion of regional old-age mortality rates due to late-life migration in the Netherlands? Demographic Research 2013;29(5):105-32

38

Knol W, van Marum RJ, Jansen PA, Strengman E, Al Hadithy AF, Wilffert B, Schobben AF, Ophoff RA, Egberts TC. Genetic Variation and the Risk of Haloperidol-Related Parkinsonism in Elderly Patients: A Candidate Gene Approach. J Clin Psychopharmacol 2013;33(3):405-10

39

Kotsopoulos N, Connolly MP, Sobanski E, Postma MJ. The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings. J Ment Health Policy Econ 2013;16(1):27-33

40

Kotsopoulos N, Connolly MP, Postma MJ, Hutubessy RC. Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation. Vaccine 2013;

41

Kotsopoulos N, Connolly MP, Sobanski E, Postma MJ. Assessing the economic burden and benefit-cost of treating attention-deficit hyperactivity disorder in Germany, Journal of Health Economics and Outcomes Research (JHEOR) 2013;1:212-23.

42

Lako IM, Bruggeman R, Liemburg EJ, van den Heuvel ER, Knegtering H, Slooff CJ, Wiersma D, Taxis K. A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects. Schizophr Res 2013;147(1):175-80

43

Lako IM, van den Heuvel ER, Knegtering H, Bruggeman R, Taxis K. Estimating dopamine D₂ receptor occupancy for doses of 8 antipsychotics: a meta-analysis. J Clin Psychopharmacol. 2013 Oct;33(5):675-81

44

Le HH, Hodgkins P, Postma MJ, Kahle J, Sikirica V, Setyawan J, Erder MH, Doshi JA. Economic impact of childhood/adolescent ADHD in a European setting: the Netherlands as a reference case, Eur Child Adolesc Psychiatry 2013.

45 Leendertse AJ, de Koning GH, Goudswaard AN, Belitser SV, Verhoef M, de Gier HJ, Egberts AC, van den Bemt PM.Preventing hospital admissions by reviewing medication (PHARM) in primary care: an open controlled study in an elderly population. J Clin Pharm Ther 2013;38(5):379-87
46

Loonen AJ and Ivanova SA. New insights into the mechanism of drug-induced dyskinesia. CNS Spectr 2013;18(1):15-20

47 Luttjeboer J, Westra TA, Wilschut JA, Nijman HW, Daemen T, Postma MJ. Cost-effectiveness of the prophylactic HPV vaccine: An application to the Netherlands taking non-cervical cancers and cross-protection into account. Vaccine 2013;
48

Mapako T, Mvere DA, Chitiyo ME, Rusakaniko S, Postma MJ, van Hulst M. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety. Transfusion 2013;

49

Meijboom MJ, Pouwels K, Luytjes W, Postma MJ, Hak E. RSV vaccine in development: Assessing the potential cost-effectiveness in the Dutch elderly population, Vaccine 2013.

50

Mihajlović J, Pechlivanoglou P, Miladinov-Mikov M, Zivkovic S, Postma MJ. Cancer incidence and mortality in Serbia 1999-2009, BMC Cancer 2013;13:18-2407-13-8.

51 Mihajlović J, Pechlivanoglou P, Sabo A, Tomić Z, Postma MJ. Cost-Effectiveness of Everolimus for Second-Line Treatment of Metastatic Renal Cell Carcinoma in Serbia. Clin Ther. 2013 Nov 13. doi:pii: S0149-2918(13)01023-0. [Epub ahead of print].
52

Monteiro SP, Huiskes R, Van Dijk L, Van Weert JC, De Gier JJ. How effective are pictograms in communicating risk about driving-impairing medicines? Traffic Inj Prev 2013;14(3):299-308

53

Mulder B, Schuiling-Veninga CC, Bos JH, de Vries TW, Hak E. Acid-suppressive drug use in pregnancy and the toddler's asthma risk: A crossover, case-control study. J Allergy Clin Immunol 2013;

54

Mulder B, Schuiling-Veninga C, Bos H, De Vries T, Jick S, Hak E. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study, Clin Exp Allergy 2013.

55

Munster JM, Leenders AC, Hamilton CJ, Meekelenkamp JC, Schneeberger PM, van der Hoek W, Rietveld A, de Vries E, Stolk RP, Aarnoudse JG, Hak E. Routine screening for Coxiella burnetii infection during pregnancy: a clustered randomised controlled trial during an outbreak, the Netherlands, 2010. Euro Surveill 2013;18(24):20504

56

Nguyen HT, Pham HT, Vo DK, Nguyen TD, van den Heuvel ER, Haaijer-Ruskamp FM, Taxis K. The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after study. BMJ Qual Saf. 2013 Nov 6. [Epub ahead of print]

57

Parouty MB, Krooshof DG, Westra TA, Pechlivanoglou P, Postma MJ. Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time. Expert Rev Pharmacoecon Outcomes Res 2013;13(4):523-47

58

Pechlivanoglou P, Le HH, Daenen S, Snowden JA, Postma MJ. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. J Antimicrob Chemother 2013;

59

Postma MJ, Kappelhoff BS, van Hulst M, Brouwers JR. Author response : economic evaluation of dabigatran etexilate. J Med Econ 2013;16(3):372-3

60

Postma MJ, Westra TA, Quilici S, Largeron N. Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples. Expert Rev Vaccines 2013;12(5):555-65

61

Postma MJ, Parouty M, Westra TA. Accumulating evidence for the case of differential discounting, Expert Rev Clin Pharmacol 2013;6:1-3.

62

Postma MJ, Standaert BA. Economics of vaccines revisited, Hum Vaccin Immunother 2013;9.

63

Postma MJ, Top G, Buskens E. Healthy aging through lifelong vaccination: a tale of two countries, Aging Health 2013;9:619-27.

64

Pouwels KB, Visser ST, Hak E. Effect of pravastatin and fosinopril on recurrent urinary tract infections. J Antimicrob Chemother 2013;68(3):708-14

65

Pouwels KB, Hak E, van der Ende A, Christensen H, van den Dobbelsteen GP, Postma MJ. Cost-effectiveness of vaccination against meningococcal B among Dutch infants: Crucial impact of changes in incidence. Hum Vaccin Immunother 2013;9(5)

66

Pouwels KB, Visser ST, Bos HJ, Hak E. Angiotensin-Converting Enzyme Inhibitor Treatment and the Development of Urinary Tract Infections: A Prescription Sequence Symmetry Analysis. Drug Saf 2013;

67

Pouwels KB, Kalkman GA, Schagen D, Visser ST, Hak E. Is combined use of SSRIs and NSAIDs associated with an increased risk of starting peptic ulcer treatment? Br J Clin Pharmacol 2013.

68

Rahamat-Langendoen JC, Riezebos-Brilman A, Hak E, Scholvinck EH, Niesters HG. The significance of rhinovirus detection in hospitalized children: clinical, epidemiological and virological features. Clin Microbiol Infect 2013;

69

Riphagen-Dalhuisen J, Burgerhof J, Frijstein G, van der Geest-Blankert A, Danhof-Pont M, de Jager H, Bos A, Smeets E, de Vries M, Gallee P, Hak E. Hospital-based cluster randomised controlled trial to assess effects of a multi-faceted programme on influenza vaccine coverage among hospital healthcare workers and nosocomial influenza in the Netherlands, 2009 to 2011. Euro Surveill 2013;18(26):20512

70

Riphagen-Dalhuisen J, Frijstein G, van der Geest-Blankert N, Danhof-Pont M, de Jager H, Bos N, Smeets E, de Vries M, Gallee P, Hak E. Planning and process evaluation of a multi-faceted influenza vaccination implementation strategy for health care workers in acute health care settings. BMC Infect Dis 2013;13:235,2334-13-235

71

Rolfes L, Wilkes S, van Hunsel F, van Puijenbroek E, van Grootheest K. Important information regarding reporting of adverse drug reactions: a qualitative study. Int J Pharm Pract 2013;

72

Rozenbaum MH and Postma MJ. Response on "RE: Cost-effectiveness of pertussis booster vaccination in the Netherlands". Vaccine 2013;31(16):2024

73

Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ, Hak E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis 2013;32(3):305-16

74 Standaert B, Gomez JA, Raes M, Debrus S, Velazquez FR, Postma MJ. Impact of rotavirus vaccination on hospitalisations in belgium: comparing model predictions with observed data, PLoS One 2013;8:e53864.
75

Stoeldraijer L, van Duin C, Van Wissen LJG, Janssen F. Sensitivity of future life expectancy at birth and at age 65 due to different mortality forecasting methods. Demographic Research 2013;29(13):323-54

76

Stuurman-Bieze AG, Hiddink EG, van Boven JF, Vegter S. Proactive pharmaceutical care interventions improve patients' adherence to lipid-lowering medication. Ann Pharmacother 2013;47:1448-56

77

Suwantika AA, Tu HA, Postma MJ. Cost-effectiveness of rotavirus immunization in Indonesia: Taking breastfeeding patterns into account. Vaccine 2013;31(32):3300-7

78 Suwantika AA, Yegenoglu S, Riewpaiboon A, Tu HA, Postma MJ. Economic evaluations of hepatitis A vaccination in middle-income countries, Expert Rev Vaccines 2013.
79

ter Horst PG, Bos HJ, de Jong-van de Berg LT, Wilffert B. In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children. Eur J Clin Pharmacol 2013;69(3):541-7

80

Tu HA, Rozenbaum MH, de Boer PT, Noort AC, Postma MJ. An update of "Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model", BMC Infect Dis 2013;13:54-2334-13-54.

81

Urbanus AT, van Keep M, Matser AA, Rozenbaum MH, Weegink CJ, van den Hoek A, Prins M, Postma MJ. Is adding HCV screening to the antenatal national screening program in amsterdam, the Netherlands, cost-effective? PLoS One 2013;8(8):e70319

82

van Boven JF, de Boer PT, Postma MJ, Vegter S. Persistence with osteoporosis medication among newly-treated osteoporotic patients. J Bone Miner Metab 2013;

83

van Boven JF, de Jong-van den Berg LT, Vegter S. Inhaled corticosteroids and the occurrence of oral candidiasis: a prescription sequence symmetry analysis. Drug Saf 2013;36(4):231-6

84

van Boven JF, Hiddink EG, Stuurman-Bieze AG, Schuiling-Veninga CC, Postma MJ, Vegter S. The pharmacists' potential to provide targets for interventions to optimize pharmacotherapy in patients with asthma. Int J Clin Pharm 2013;35:1075-82

85

van Boven JF, Chavannes NH, van der Molen T, Rutten-van Molken MP, Postma MJ, Vegter S. Clinical and economic impact of non-adherence in COPD: A systematic review. Respir Med 2013;

86

van Boven JF, Vegter S, van der Molen T, Postma MJ. COPD in the Working Age Population: The Economic Impact on Both Patients and Government. COPD 2013;

87

van der Elst KC, Span LF, van Hateren K, Vermeulen KM, van der Werf TS, Greijdanus B, Kosterink JG, Uges DR, Alffenaar JW. Dried blood spot analysis suitable for therapeutic drug monitoring of voriconazole, fluconazole and posaconazole. Antimicrob Agents Chemother 2013;

88

van der Veen W, de Gier HJ, van der Schaaf T, Taxis K, van den Bemt PM. Risk analysis and user satisfaction after implementation of computerized physician order entry in Dutch hospitals. Int J Clin Pharm 2013;35(2):195-201

89

van Gelder MM, Bos JH, Roeleveld N, de Jong-van den Berg LT. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009. Hum Reprod 2013;

90

van Hasselt FM, Coehorst Y, Wilffert B, Loonen AJ. Influencing CYP enzymes to boost psychiatric treatment: a review on clinical evidence. Pharmacopsychiatry 2013;46(2):43-6

91

van Hasselt FM, Schorr SG, Mookhoek EJ, Brouwers JR, Loonen AJ, Taxis K. Gaps in health care for the somatic health of outpatients with severe mental illness. Int J Ment Health Nurs 2013;22(3):249-55

92 van Hasselt FM, Krabbe PF, van Ittersum DG, Postma MJ, Loonen AJ. Evaluating interventions to improve somatic health in severe mental illness: a systematic review. Acta Psychiatr Scand 2013;3524
93

van Hasselt FM, Thier CSM, van Rijswijk E, Loonen AJM. Is somatic health screening in patients with severe mental illness of added value? Perspect Psychiatr Care 2013;doi: 10.1111/ppc.12042

94

van Hasselt FM, Oud MJT, Loonen AJM. Improvement of care for the physical health of patients with severe mental illness: a qualitative study assessing the view of patients and families. BMC Health Services Research.2013, 13:426. DOI: 10.1186/1472-6963-13-426

95

van Leeuwen RW, Brundel DH, Neef C, van Gelder T, Mathijssen RH, Burger DM, Jansman FG. Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. Br J Cancer 2013;108(5):1071-8

96

Vegter S, de Boer P, van Dijk KW, Visser ST, de Jong-van den Berg LT. The Effects of Antitussive Treatment of ACE Inhibitor-Induced Cough on Therapy Compliance: A Prescription Sequence Symmetry Analysis. Drug Saf 2013;

97

Vegter S, Tolley K, Wilson Waterworth T, Jones H, Jones S, Jewell D. Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis. Aliment Pharmacol Ther 2013;38(3):284-93

98

Verstappen GM, Smolders EJ, Munster JM, Aarnoudse JG, Hak E. Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands. BMC Public Health 2013;13:185,2458-13-185

99

Visser ST, Schuiling-Veninga CC, Bos JH, de Jong-van den Berg LT, Postma MJ. The population-based prescription database IADB.nl: its development, usefulness in outcomes research and challenges. Expert Rev Pharmacoecon Outcomes Res 2013;13(3):285-92

100

Vriend HJ, Lugner AK, Xiridou M, Schim van der Loeff MF, Prins M, de Vries HJ, Geerlings SE, Prins JM, Rijnders BJ, van Veen MG, Fennema JS, Postma MJ, van der Sande MA. Sexually transmitted infections screening at HIV treatment centers for MSM can be cost-effective. AIDS 2013;27(14):2281-90

101

Vu DH, Koster RA, Wessels AM, Greijdanus B, Alffenaar JW, Uges DR. Troubleshooting carry-over of LC-MS/MS method for rifampicin, clarithromycin and metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2013;917-918:1-4

102 Westra AE, van Gils EJ, Aarts F, Rodenburg GD, Veenhoven RH, Hak E, Scharloo M, Sukhai RN, Wit JM, de Beaufort I, Sanders EL. Perceived discomfort levels in healthy children participating in vaccine research. J Empir Res Hum Res Ethics 2013;8(3):66-72
103

Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands, BMC Infect Dis 2013;13:75.

104

Wilffert B, Swen J, Mulder H, Touw D, Maitland-Van der Zee AH, Deneer V, KNMP working group Pharmacogenetics. From evidence based medicine to mechanism based medicine. Reviewing the role of pharmacogenetics. Int J Clin Pharm 2013;35(3):369-75

105 Wirtz VJ, Mol PG, Verdijk J, Vander Stichele RH, Taxis K. Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009, Trop Med Int Health 2013.
106

Xiridou M, Vriend HJ, Lugner AK, Wallinga J, Fennema JS, Prins JM, Geerlings SE, Rijnders BJ, Prins M, de Vries HJ, Postma MJ, van Veen MG, Schim van der Loeff MF, van der Sande MA. Modelling the impact of chlamydia screening on the transmission of HIV among men who have sex with men. BMC Infect Dis 2013;13(1):436

107

Yska JP, van der Linde S, Tapper VV, Apers JA, Emous M, Totte ER, Wilffert B, van Roon EN. Influence of Bariatric Surgery on the Use and Pharmacokinetics of Some Major Drug Classes. Obes Surg 2013;3513

Scientific publication national
1

Härmark L, van Puijenbroek E, van Grootheest K. Het volgen van bijwerkingen in de tijd met webbased intensive monitoring – pregabaline als voorbeeld. Pharmaceutisch Weekblad Wetenschappelijk Platform 2013; 7: a1309.

2 Mol PG, van den Bemt PM, Dequito AB, van Doormaal JE, Zaal RJ, Haaijer-Ruskamp FM, Kosterink JG. Preventable and non-preventable medication-related injuries incurred in hospitals, Ned Tijdschr Geneeskd 2013;157:A5051.
3

Pouwels K, van Grootheest K. De besluitvorming over werkzaamheid en veiligheid van rosiglitazon bij de FDA en de EMA. Wat zijn de lessen? Pharmaceutisch Weekblad Wetenschappelijk Platform 2013; 7(6): a1319.

4

ter Horst PGJ, Bos JH, de Jong-van den Berg LTW, Wilffert B. Antidepressiva tijdens de zwangerschap en het gebruik van luchtwegmedicatie door de nakomelingen. Pharmaceutisch Weekblad Wetenschappelijk Platform 2013;7(9):102-7

5

Wilffert B. Proteomics voor schatting nierschade bij diabetici. Pharmaceutisch Weekblad Wetenschappelijk Platform 2013;7(1):e1305

6

Wilffert B. Ongeschikte medicatie bij ouderen opsporen met Nederlandse versie STOPP en START. Pharmaceutisch Weekblad Wetenschappelijk Platform 2013;7(2):e1304

7

Wilffert B. LPA-polymorfisme karakteriseert hartpatiënten die kwetsbaar zijn ondanks statines. Pharmaceutisch Weekblad Wetenschappelijk Platform 2013;7(12):e1334

8

Wilffert B. Afwegingen en besluitvorming door toelatingsautoriteiten. Pharmaceutisch Weekblad Wetenschappelijk Platform 2013;7(12):e1335

Professional
1 Brouwers J.R.B.J. Calcium en vitamine D-suppletie bij ouderen: te veel en te weinig. Ins&Ouds-Tijdschrift voor Geriatrie 2013;3:6-10
2

Brouwers JRBJ, Jansen PAF. Geneesmiddelen bij kwetsbare ouderen. MFM-Tijdschrift Praktische Farmacotherapie 2013;3:54-6

3

Cohen D, Loonen AJM. Substitutie vaak riskant. Psychofarmaca: pas op met uitwisselen directe en gereguleerde afgifte. Pharmaceutisch Weekblad 2013:148(2):19-21

4

de Jong J. Meer aandacht voor goed gebruik antibiotica bij kinderen, Pharmaceutisch weekblad-Nieuwsberichten;23-05-2013

5 de Jong J. Minder antibioticagebruik bij kind mogelijk, Pharmaceutisch weekblad-Rubrieken;23-08-2013
6

Härmark L, van Puijenbroek EP, de Gier H, & van Grootheest AC. Lareb intensive monitoring boekt succes; systematischer inzicht in bijwerkingen. Pharmaceutisch Weekblad 2013, 148(8), 18-20

7

Hovens JE, Loonen AJM. Reactie op ‘Na de extramuralisering. II. Een crosssectionele studie naar psychisch en sociaal functioneren en kwaliteit van leven van een steekproef van chronische psychiatrische patiënten in de Amsterdamse GGZ. Tijdschr Psychiatr. 2013;55(5):387-8

8

Keijsers CJPW, Jansen PAF, de Wildt DJ, Brouwers JRBJ. (2013). Rationeel voorschrijven bij ouderen: Innovatie in het farmacotherapieonderwijs. Ins&Ouds-Tijdschrift voor Geriatrie 2013;1;9-12

9

Lokhorst B, van Grootheest K. Acne-achtige bultjes door vitamine B12. Pharmaceutisch Weekblad 2013;148(14):16-7

10

Loonen AJM. Een moeder die haar kind achterliet in de ballenbak. Psyfar 2013: 8 (1; maart): 32-5

11

Stoeldraijer L, van Duin C, Janssen F. Bevolkingsprognose 2012-2060: Model en veronderstellingen betreffende de sterfte. [Population forecast 2012-2060: Model and assumptions on mortality] . Bevolkingstrends 2013;juni:1-27

12

Taxis K. Kleiner Nachbar ganz groß. Das Studienfach Klinische Pharmazie in den Niederlanden. Deutsche Apotheker Zeitung 2013;36:3000-4

13

ter Horst PGJ, Bos JH, de Jong-van den Berg LTW, Wilffert B. Grote rol apotheker bij depressieve zwangere. Pharmaceutisch weekblad 2013;148(34):18-20

14

van Grootheest AC. Geneesmiddelen in Afrika – een persoonlijke kijk. Folia Pharmaceutica 2013;100(2):22-3

15

van Ojik AL, Jansen PAF, Brouwers JRBJ, van Roon EN. Antipsychotica bij ouderen met een delier-welk middel wel en welk niet? Ins&Ouds-Tijdschrift voor Geriatrie 2013; 7;1-13

16 van Ojik AL, Jansen PAF, Brouwers JRBJ, van Roon EN. Evidence based keuze van opioiden bij ouderen met chronische pijn. I ns&Ouds-Tijdschrift voor Geriatrie 2013;3:11-15
17

van Strien AM, Keijsers CJPW, Schuoten HJ, Brouwers JRBJ. Factor Xa remmers en directe trombineremmers, nieuwe orale anticoagulantis bij kwetsbare ouderen? Ins&Ouds-Tijdschrift voor Geriatrie 2013;3:16-23

18

Vegter S, Postma MJ. Zijn weesgeneesmiddelen te duur? Foliolum 2013;2:13-15

19 Woerdenbag HJ, Brouwers JRBJ. Traditionele geneeskunde in Vietnam, Ned Tijdschr Fytotherapie 2013;26:9-13
Book (whole)
1 Brouwers JRBJ, Hendriks JML, Jukema GJ, van Laarhoven H. Patiënt relevantie en validatieprocedure: Het patiënten perspectief op antistollingsbehandeling van diepe veneuze trombose en longembolie (VTE). Uitgaaf Europe-Expro Munchen 2013, 70 blz. ISBN:978 949 152 6039
2

de Gier JJ, Bouvy ML, Egberts ACG, de Smet PAGM. Handboek Farmaceutische Patiëntenzorg. Achtergronden En Praktijk. Uitgaaf Prelum: Houten 2013, 331 blz. ISBN: 978 908 562 1263

3

Loonen AJM. Het beweeglijke brein. Uitgaaf Mension, Haarlem 2013;Tweede editie: 415 blz ISBN: 978 907 732 2109

Book (chapter)
1

de Gier JJ. Medicines & driving: results of the European DRUID project. [ЛЕКАРСТВЕННЫЕ СРЕДСТВА И ВВЖДЕНИЕ: РЕЗУЛЬТАТЫ ЕВРВПЕИСКВГВ ПРВЕКТА BRUIB]. 2013;Chapter 2:16-49

2

Dijkstra A, Schaafsma E. Hoofdstuk 7. Psychologie van gedragsverandering en counseling. In: JJ de Gier, ML Bouvy, ACG Egberts, PAGM de Smet (Eds) Handboek farmaceutische patiëntenzorg: achtergronden en praktijk 2013:83-100

3

Loonen AJM. СЕРОТОНИН: ФУНКЦИИ, МЕТАБОЛИ3М, РЕЦЕПТОРЫ. [Serotonin: function metabolism receptor.] In: Bokhan NA, Ivanova SA, Levchuk LA, eds. Серотониновая Система в модуляции депрессивных и аддиктивного поведения. 2013;(Chapter 1):11-30.

4 Postma MJ, Boersma C, Vegter S, Vandijck D, Annemans L. Pharmacoeconomics of Pharmacogenetics within the Context of General Health Technology Assessments. In: YWF Lam, LH Cavallari (Eds) Pharmacogenomics 2013;Chapter 12:429-50
5

van Bodegraven AA, van Weyenberg SJB, Wierdsma NJ, de Wit NJ, Brouwers JRBJ. Diagnose en therapie 2013-2014. In: van Everdingen JJE en anderen. (Ed.) Chapter 12: 394-431

6 van Hulst M, Postma MJ. Health Economics of Technologies in Blood Transfusion within the Context of General HTAs. In: Cees Th. Smit Sibinga. (Ed.) Quality Management in Transfusion Medicine. Nova Science Publishers: New York, 2013 Chapter XII:385-411.
7

Vegter S, van Boven JF, Hiddink EG, Postma MJ. Hoofdstuk 21. Economische uitkomsten. In: JJ de Gier, ML Bouvy, ACG Egberts, PAGM de Smet (Eds) Handboek farmaceutische patiëntenzorg: achtergronden en praktijk 2013:275-82

Laatst gewijzigd:19 april 2016 09:34